Health product recall

Teva-Losartan (2021-08-26)

Starting date:
August 26, 2021
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-76341

Last updated: 2021-08-30

Summary

  • Product: Teva-Losartan

Reason

Presence of Losartan Azide impurity above the acceptable limit.

Affected products

Teva-Losartan

DIN, NPN, DIN-HIM

DIN 02380838

Dosage form

Tablet 

Strength

Losartan Potassium 25 Mg

Lot or serial number

0040917

Companies

Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA

Teva-Losartan

DIN, NPN, DIN-HIM

DIN 02357968

Dosage form

Tablet

Strength

Losartan Potassium 50 Mg

Lot or serial number

1070917, 1020419, 1030419

Companies

Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA

Teva-Losartan

DIN, NPN, DIN-HIM

DIN 02357976

Dosage form

Tablet

Strength

Losartan Potassium 100 Mg

Lot or serial number

2050419

Companies

Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA